Our findings suggested that bergenin could be a therapeutic agent for pulmonary fibrosis treatment, and we propose that the p62–Nrf2 regulatory loop may be a potential therapeutic target for pulmonary fibrosis. Here, SQSTM1 is linked to pulmonary fibrosis.